With the passage of the FDA Modernization Act 2.0, the pharmaceutical industry is poised to expand their research toolkit with a plethora of alternative models, including Organ-Chips. While this represents a pivotal moment in moving towards a new human-centric era in drug development, many may be asking how they can start incorporating these new technologies into their own research and, more importantly, how advanced in vitro tools like Organ-Chips can inform better decision-making throughout the drug development pipeline.
Working with Organ-Chip service providers is one of the easiest ways to begin benefiting from this technology. By collaborating with Emulate, the pioneer of Organ-on-a-Chip technology, researchers gain access to a team of scientists with industry-leading expertise in designing and executing bespoke experiments across a wide range of validated Organ-Chip models and applications. View this webinar to learn more about the types of Organ-on-a-Chip services we offer as well as our end-to-end process of designing studies tailored to each client’s needs.
In this webinar, you will learn:
- How outsourcing Organ-Chip studies can de-risk drug development and improve decision making in each phase of the drug development pipeline
- Which factors you should consider in selecting an Organ-Chip service provider
- What the process is for performing contract research studies at Emulate
- Data-driven case studies on how collaborating with Emulate allowed pharmaceutical companies to make better-informed decisions in their drug development programs